Reagenzgläser
Vesalius Biocapital

A European life sciences venture capital investor

.

About us

Vesalius Biocapital is a European life sciences venture capital investor. The active fund Vesalius Biocapital III had a first closing in May 2017 – currently, over € 75 million are managed.

We are investing in appealing, later-stage companies in drug development, medical devices & diagnostics and eHealth / mHealth, predominantly in Europe. Our portfolio companies address unmet medical & market needs and operate on the basis of strong intellectual property protection.

 

Fund 3

Vesalius Biocapital III

Vintage 2017 - >€70 million assets under management (first closing). In investment mode

read more

 

News

Vesalius News

Vesalius Biocapital III Partners joins Forendo Pharma Investor Syndicate
read more
SWORD Health secures $4.6 million in seed funding
read more
Vesalius Biocapital Launches New Fund in Collaboration with Portuguese National Promotional Bank (IFD)
read more
.

xxnoxx_zaehler